BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11985562)

  • 1. Lessons from the audit of invasive cervical cancer.
    Shaw PA
    Cytopathology; 2002 Feb; 13(1):1-3. PubMed ID: 11985562
    [No Abstract]   [Full Text] [Related]  

  • 2. A smear on audit. Implications of the Leicester cervical smear audit.
    Symonds P; Naftalin N; Shaw P
    BJOG; 2003 Jul; 110(7):646-8. PubMed ID: 12842054
    [No Abstract]   [Full Text] [Related]  

  • 3. Cervical cytology screening in HIV-positive women: completion of the audit cycle.
    Bates SM; Street EJ
    Int J STD AIDS; 2011 Oct; 22(10):615-6. PubMed ID: 21998191
    [No Abstract]   [Full Text] [Related]  

  • 4. Should we abandon pap smear testing?
    DeMay RM
    Am J Clin Pathol; 2000 Nov; 114 Suppl():S48-51. PubMed ID: 11996169
    [No Abstract]   [Full Text] [Related]  

  • 5. The audit of cervical cytology screening programmes: discussion paper.
    Ewart HE
    J R Soc Med; 1991 Aug; 84(8):488-90. PubMed ID: 1886118
    [No Abstract]   [Full Text] [Related]  

  • 6. Audit shows weaknesses in cervical cancer screening.
    Ferriman A
    BMJ; 2001 May; 322(7295):1141. PubMed ID: 11348903
    [No Abstract]   [Full Text] [Related]  

  • 7. Frequency and outcome of cervical cancer prevention failures in the United States.
    Raab SS; Grzybicki DM; Zarbo RJ; Jensen C; Geyer SJ; Janosky JE; Meier FA; Vrbin CM; Carter G; Geisinger KR
    Am J Clin Pathol; 2007 Nov; 128(5):817-24. PubMed ID: 17951205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine audit of large-scale cervical cancer screening programs.
    Cuzick J
    J Natl Cancer Inst; 2008 May; 100(9):605-6. PubMed ID: 18445817
    [No Abstract]   [Full Text] [Related]  

  • 9. Sensitivity of primary screening by rapid review: 'to act or not to act on the results, that is the question'.
    Slater DN
    Cytopathology; 1998 Apr; 9(2):77-83. PubMed ID: 9577733
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Saitas et al.
    Melamed MR
    Diagn Cytopathol; 1998 Mar; 18(3):247. PubMed ID: 9523148
    [No Abstract]   [Full Text] [Related]  

  • 11. Pitfalls in the screening and early diagnosis of cervical cancer.
    Wain GV; Hacker NF
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):74-9. PubMed ID: 2102310
    [No Abstract]   [Full Text] [Related]  

  • 12. Reasons for variation in coverage in the NHS cervical screening programme.
    McGahan CE; Blanks RG; Moss SM
    Cytopathology; 2001 Dec; 12(6):354-66. PubMed ID: 11843937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is cervical screening necessary in older women?
    Cruickshank ME
    Cytopathology; 2001 Dec; 12(6):351-3. PubMed ID: 11843936
    [No Abstract]   [Full Text] [Related]  

  • 15. Stat bite: Frequency of cervical cancer screening by health plan, 2000-2003.
    J Natl Cancer Inst; 2004 Dec; 96(23):1741. PubMed ID: 15572755
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cytological diagnosis and invasive cervix cancer].
    Gårdmark S; Johnsson JE; Sjöberg NO; Stormby N
    Lakartidningen; 1979 Jan; 76(5):279-80. PubMed ID: 759773
    [No Abstract]   [Full Text] [Related]  

  • 17. Bayesian analysis of binary data from an audit of cervical smears.
    Raab GM; Elton RA
    Stat Med; 1993 Dec; 12(23):2179-89. PubMed ID: 8310188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer audit: and what is quality?
    Wilson PO
    Cytopathology; 2002 Jun; 13(3):141-4. PubMed ID: 12060075
    [No Abstract]   [Full Text] [Related]  

  • 19. National cervical screening programme.
    Slater D
    BMJ; 1990 Oct; 301(6757):887-8. PubMed ID: 2261531
    [No Abstract]   [Full Text] [Related]  

  • 20. External quality assurance for cervical cytology in developing countries. Experience in Peru and Nicaragua.
    Salvetto M; Sandiford P
    Acta Cytol; 2004; 48(1):23-31. PubMed ID: 14969177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.